{
    "clinical_study": {
        "@rank": "92258", 
        "arm_group": [
            {
                "arm_group_label": "Product 1", 
                "arm_group_type": "Active Comparator", 
                "description": "35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)"
            }, 
            {
                "arm_group_label": "Control product", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 empty capsules"
            }
        ], 
        "brief_summary": {
            "textblock": "Grape seed proanthocyanidins have been reported to possess a hypotriglyceridemic effect\n      after an acute or chronic consumption in rodents. In this study, we aimed to investigate the\n      effects of an acute consumption of proanthocyanidins before a breakfast meal in humans.\n      Moreover, the mechanisms implicated in the reduction of plasma triglycerides levels by grape\n      seed proanthocyanidins in humans should be elucidated as well as its activity on vascular\n      function."
        }, 
        "brief_title": "Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Triglyceride Metabolism", 
            "Cardiovascular Function"
        ], 
        "detailed_description": {
            "textblock": "The intervention will consist in the administration of 2 capsules containing the grape seed\n      proanthocyanidins extract or 2 empty capsules (placebo) just before breakfast, which will\n      consist of 100g of white bread, 75g of salami, 50g of fatty cheese, 125g of yogurt (10%\n      fat), 25ml of olive oil and water ad libitum. The nutritional composition of this meal is as\n      follows: 1.200 Kcal of energy content, 15% of energy from proteins, 22% from carbohydrates\n      and 63% from fat (35% saturated fat), and 120mg of cholesterol. Blood samples will be taken\n      at point 0.5,1,2,3 and 6 hours after breakfast. Moreover, urine samples will be collected at\n      time 0 and 6 hours."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults between the ages of 20 and 40\n\n          -  Signing the informed consent\n\n        Exclusion Criteria:\n\n          -  Body mass index (BMI) lower than 18.5 or greater than 27 Kg/m2\n\n          -  Smokers\n\n          -  Regular medication\n\n          -  Consumption of medication during the last week\n\n          -  Following a weight-loss diet\n\n          -  Vegetarians\n\n          -  Abnormal glucose levels\n\n          -  Diabetes\n\n          -  Cardiovascular disease\n\n          -  Gastrointestinal disease\n\n          -  Anemia\n\n          -  Nuts allergy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "16", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01688154", 
            "org_study_id": "306724"
        }, 
        "intervention": [
            {
                "arm_group_label": "Product 1", 
                "intervention_name": "35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Control product", 
                "intervention_name": "2 empty capsules", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Proanthocyanidin", 
                "Procyanidin", 
                "Grape Seed Extract"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 2, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Reus", 
                        "country": "Spain", 
                        "state": "Tarragona", 
                        "zip": "43204"
                    }, 
                    "name": "Technological Center of Nutrition and Health (CTNS)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reus", 
                        "country": "Spain", 
                        "state": "Tarragona", 
                        "zip": "43204"
                    }, 
                    "name": "CTNS"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans", 
        "overall_official": [
            {
                "affiliation": "University Rovira i Virgili", 
                "last_name": "Rosa Sol\u00e0, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University Rovira i Virgili", 
                "last_name": "Maria Cinta Blad\u00e9, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Area under the curve of plasma triglycerides concentration", 
            "safety_issue": "No", 
            "time_frame": "0-180 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01688154"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Blood pressure", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Endothelial function (assessed by ischemic reactive hyperemia)", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Blood lipid levels, markers of inflammation and oxidation", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Plasma levels of procyanidins metabolites", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Markers of cholesterol metabolism in PBMCs (mRNA and protein).", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Membrane lipid composition of erythrocytes and oxidation markers.", 
                "safety_issue": "No", 
                "time_frame": "0-0.5-1-2-3-6 hours"
            }, 
            {
                "measure": "Non-targeted metabolomics and 8-epi-prostaglandin-F2\u03b1 levels (in urine)", 
                "safety_issue": "No", 
                "time_frame": "0-6 hours"
            }
        ], 
        "source": "Technological Centre of Nutrition and Health, Spain", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University Rovira i Virgili", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Hospital Universitari Sant Joan de Reus", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Technological Centre of Nutrition and Health, Spain", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}